Traumatic cerebrovascular injury von Morales Varas, G., Morán Gallego, F., Pedrosa Guerrero, A., Merlo González, V., Márquez Doblas, M., Marina Martínez, L.

Volltext

Efectos de la vacunación contra la COVID-19 en la evolución de los pacientes críticos von Morales Varas, G., Sánchez Casado, M., Padilla Peinado, R., Morán Gallego, F., Buj Vicente, M., Rodríguez Villamizar, A.

Volltext

Effects of vaccination against COVID-19 on the evolution of critically ill patients von Morales Varas, G., Sánchez Casado, M., Padilla Peinado, R., Morán Gallego, F., Buj Vicente, M., Rodríguez Villamizar, A.

Volltext

Lesión cerebrovascular asociada a la enfermedad traumática von Morales Varas, G., Morán Gallego, F., Pedrosa Guerrero, A., Merlo González, V., Márquez Doblas, M., Marina Martínez, L.

Volltext

Efectos de la vacunación contra la COVID-19 en la evolución de los pacientes críticos von Morales Varas, G., Sánchez Casado, M., Padilla Peinado, R., Morán Gallego, F., Buj Vicente, M., Rodríguez Villamizar, A.

Volltext

Eventración abdominal con contenido visceral masivo von Borregón Rivilla, Miguel, Martínez-Barroso, Katherin, Palomares Morales, Aitana, Morán Gallego, Francisco Javier

Volltext

Traumatic cerebrovascular injury von Morales Varas, G, Morán Gallego, F, Pedrosa Guerrero, A, Merlo González, V, Márquez Doblas, M, Marina Martínez, L

Volltext

Effects of vaccination against COVID-19 on the evolution of critically ill patients von Morales Varas, G, Sánchez Casado, M, Padilla Peinado, R, Morán Gallego, F, Buj Vicente, M, Rodríguez Villamizar, A

Volltext

Can we identify a power-oriented polygenic profile? von RUIZ, Jonatan R, ARTETA, David, BUXENS, Amaya, ARTIEDA, Marta, GOMEZ-GALLEGO, Félix, SANTIAGO, Catalina, YVERT, Thomas, MORAN, Maria, LUCIA, Alejandro

Volltext

Chemoenzymatic Oxidation of Diols Catalyzed by Co‐Immobilized Flavins and Dehydrogenases von Castillo Pacheco, Sergio F., Moran, Maria Jesus, Santos, José I., Salassa, Luca, López‐Gallego, Fernando

Volltext

The K153R polymorphism in the myostatin gene and muscle power phenotypes in young, non-athletic men von Santiago, Catalina, Ruiz, Jonatan R, Rodríguez-Romo, Gabriel, Fiuza-Luces, Carmen, Yvert, Thomas, Gonzalez-Freire, Marta, Gómez-Gallego, Félix, Morán, María, Lucia, Alejandro

Volltext

Spatially resolved properties of the ionized gas in the H ii galaxy J084220+115000 von Fernández-Arenas, D, Carrasco, E, Terlevich, R, Terlevich, E, Amorín, R, Bresolin, F, Chávez, R, González-Morán, A L, Rosa-González, D, Mayya, Y D, Vega, O, Zaragoza-Cardiel, J, Méndez-Abreu, J, Izazaga-Pérez, R, Gil de Paz, A, Gallego, J, Iglesias-Páramo, J, García-Vargas, M L, Gómez-Alvarez, P, Castillo-Morales, A, Cardiel, N, Pascual, S, Pérez-Calpena, A

Volltext

OBSERVING STRATEGY FOR THE SDSS-IV/MaNGA IFU GALAXY SURVEY von Law, David R., Yan, Renbin, Bershady, Matthew A., Bundy, Kevin, Cherinka, Brian, Drory, Niv, MacDonald, Nicholas, Sánchez-Gallego, José R., Wake, David A., Weijmans, Anne-Marie, Blanton, Michael R., Klaene, Mark A., Moran, Sean M., Sanchez, Sebastian F., Zhang, Kai

Volltext

Are 'endurance' alleles 'survival' alleles? Insights from the ACTN3 R577X polymorphism von Fiuza-Luces, Carmen, Ruiz, Jonatan R, Rodríguez-Romo, Gabriel, Santiago, Catalina, Gómez-Gallego, Félix, Yvert, Thomas, Cano-Nieto, Amalia, Garatachea, Nuria, Morán, María, Lucia, Alejandro

Volltext

P1.21-04 Role of HLA-I as a Molecular Prognostic Factor for Long Term Responders in Non-small Cell Lung Cancer Patients Treated with Immunotherapy von Carcereny, E., Saigí, M., Esteve, A., Mate, J.L., Domènech, M., Andreo, F., Cerdá, G., Hernández, A., Martínez-Cardús, A., Cucurull, M., Centeno, C., Pros, E., López-Paradís, A., Morán, T., Hernández-Gallego, A., Sánchez-Céspedes, M.

Volltext

Does the ACE I/D polymorphism, alone or in combination with the ACTN3 R577X polymorphism, influence muscle power phenotypes in young, non-athletic adults? von Rodríguez-Romo, Gabriel, Ruiz, Jonatan R., Santiago, Catalina, Fiuza-Luces, Carmen, González-Freire, Marta, Gómez-Gallego, Félix, Morán, María, Lucia, Alejandro

Volltext

The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption von Giménez-Esparza, Carola, Portillo-Requena, Cristina, Colomina-Climent, Francisco, Allegue-Gallego, José Manuel, Galindo-Martínez, María, Mollà-Jiménez, Cristina, Antón-Pascual, José Luis, Mármol-Peis, Enrique, Dólera-Moreno, Cristina, Rodríguez-Serra, Manuel, Martín-Ruíz, José Luis, Fernández-Arroyo, Pablo Juan, Blasco-Císcar, Eugenia María, Cánovas-Robles, José, González-Hernández, Enrique, Sánchez-Morán, Fernando, Solera-Suárez, Manuel, Torres-Tortajada, Jesús, Palazón-Bru, Antonio, Gil-Guillen, Vicente F

Volltext

Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial von Naggie, Susanna, Boulware, David R, Lindsell, Christopher J, Stewart, Thomas G, Slandzicki, Alex J, Lim, Stephen C, Cohen, Jonathan, Kavtaradze, David, Amon, Arch P, Gabriel, Ahab, Gentile, Nina, Felker, G. Michael, Jayaweera, Dushyantha, McCarthy, Matthew W, Sulkowski, Mark, Rothman, Russell L, Wilson, Sybil, DeLong, Allison, Remaly, April, Wilder, Rhonda, Collins, Sean, Dunsmore, Sarah E, Adam, Stacey J, Thicklin, Florence, Hanna, George J, Ginde, Adit A, Castro, Mario, McTigue, Kathleen, Shenkman, Elizabeth, Hernandez, Adrian F

Volltext

Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial von McCarthy, Matthew W, Naggie, Susanna, Boulware, David R, Lindsell, Christopher J, Stewart, Thomas G, Felker, G. Michael, Jayaweera, Dushyantha, Sulkowski, Mark, Gentile, Nina, Bramante, Carolyn, Singh, Upinder, Dolor, Rowena J, Ruiz-Unger, Juan, Wilson, Sybil, DeLong, Allison, Remaly, April, Wilder, Rhonda, Collins, Sean, Dunsmore, Sarah E, Adam, Stacey J, Thicklin, Florence, Hanna, George, Ginde, Adit A, Castro, Mario, McTigue, Kathleen, Shenkman, Elizabeth, Hernandez, Adrian F

Volltext

134MO Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab + CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CL... von Lordick, F., Shah, M.A., Shitara, K., Ajani, J.A., Bang, Y-J., Enzinger, P.C., Ilson, D.H., van Cutsem, E., Gallego Plazas, J., Huang, J., Shen, L., Oh, S.C., Sunpaweravong, P., Soo, H.H.F., Türk, H.M., Park, J.W., Moran, D., Bhattacharya, P., Cao, Y.J., Xu, R-H.

Volltext